RIGEVIDON

This brand name is authorized in Austria, Ecuador, Finland, Hong Kong SAR China, Lithuania, Poland, Romania, Spain, UK.

Active ingredients

The drug RIGEVIDON contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII 423D2T571U - ETHINYL ESTRADIOL
 

Ethinylestradiol is chemically and biologically identical to endogenous human oestradiol. It substitutes for the loss of estrogen production in menopausal women, and alleviates menopausal symptoms. Estrogens prevent bone loss following menopause or ovariectomy.

 
Read more about 17 alpha-Ethinylestradiol
2
UNII 5W7SIA7YZW - LEVONORGESTREL
 

The precise mode of action of levonorgestrel as an emergency contraceptive is not known. At the recommended regimen, levonorgestrel is thought to work mainly by preventing ovulation and fertilisation if intercourse has taken place in the preovulatory phase, when the likelihood of fertilisation is the highest.

 
Read more about Levonorgestrel

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 RIGEVIDON Coated tablet MPI, EU: SmPC Web Search

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
G03AA07 Levonorgestrel and ethinylestradiol G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03A Hormonal contraceptives for systemic use → G03AA Progestogens and estrogens, fixed combinations
Discover more medicines within G03AA07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria 26.633-10-05
ES Centro de información online de medicamentos de la AEMPS 68970
FI Lääkealan turvallisuus- ja kehittämiskeskus 090327
GB Medicines & Healthcare Products Regulatory Agency 173468
HK Department of Health Drug Office 45789
LT Valstybinė vaistų kontrolės tarnyba 1012317, 1012318, 1074198, 1080875
PL Rejestru Produktów Leczniczych 100101465, 100298806, 100410628, 100410835
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W01969001, W01969002

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.